Key Companies Covered in the Global Micro Syringes Market Research Report by Research Nester Are Innovative Labor Systeme GmbH, GL Science, Inc., PerkinElmer, Inc., Trajan Scientific and Medical, Agilent Technologies, Inc., Shimadzu Corporation, Avantor, Inc., ITO Corporation, Merck KGaA, Thermo Fisher Scientific Inc., and other key market players.
New York, July 26, 2022 (GLOBE NEWSWIRE) -- Worldwide, at least 16 billion shots are given each year. 90% or more of the time is spent in therapeutic care. Around 5% of all syringes are used for immunization, with the remainder going toward injectable contraception, intravenous medication, and fluid administration, and blood and blood product transfusion. According to surveys done in a variety of settings, a large percentage of prescriptions (up to 56%) contain at least one injectable preparation, and the annual ratio of injections per person ranged from 1.7 to 11.3%
Research Nester has published a detailed market report on ‘Global Micro Syringes Market’ for the forecast period i.e., 2022 – 2031 which includes the ongoing industry innovations and recent trends being adopted by the major industry players to achieve their business targets. Apart from that, the inclusive data on market size, growth rate, market revenue share, growth opportunities and challenges for the market players along with worldwide analysis on five major regions – North America, Latin America, Europe, Asia Pacific and Middle East & Africa has been provided in the report.
According to the data by UNICEF, in comparison to an average year, the volume of syringes purchased in 2021 (for routine vaccination and the COVID-19 response) increased four-fold ranging from 600 million on an average year to around 2.4 billion in 2021. The global micro syringes market to grow at a significant CAGR over the forecast period. The growth of the market can be attributed to the rising demand for microliter syringes for sample collection or precise drug delivery. Micro syringes are used to inject fluids into patients and draw fluid from their bodies. They are designed specifically for homogeneous liquids. Given the small diameter of the syringe, micro syringes are also used to measure and dosage chemicals very precisely. Furthermore, the increasing cases of Covid-19 across the globe and rising vaccination drive to limit Covid-19 cases are expected to drive the market growth during the forecast period. As per WHO surveys, globally, 6,334,728 deaths from COVID-19, including 545,226,550 confirmed cases, have been recorded and at least one dose of the COVID-19 vaccine has been administered to 66.5% of the world's population. In total, 12.09 billion doses have been induced, and 5.74 million are now given daily.
Get a sample copy of the report@ https://www.researchnester.com/sample-request-3989
In addition to this, the increasing clinical trials, preclinical services, and rising investment in research and development activities across the globe are expected to fuel the market growth over the ensuing years. It is found that global research and development spending has more than tripled in real terms since 2000, rising from USD 677 billion to USD 2.2 trillion in 2019. Furthermore, technological advancement, rising patient pool in the hospitals and laboratories, and increasing healthcare spending are estimated to drive the market growth over the forecast period. As per the World Health Organization, global health spending has increased overall during the previous 20 years, doubling in real terms, reaching USD 8.5 trillion in 2019 and 9.8% of GDP up from 8.5 percent in 2000.
On the basis of geographical analysis, the global micro syringes market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa region. Out of these, North America region is estimated to hold the largest market share over the forecast period owing to high healthcare spending, advancement in healthcare infrastructure, and an increasing emphasis on medical R&D activities. As per the expenditure data report, spending on health care in the United States increased by 9.7% in 2020 to USD 4.1 trillion, or USD 12,530 per person. The amount spent on health represented 19.7% of the country's GDP.
For more information in the analysis of this report, visit: https://www.researchnester.com/reports/micro-syringes-market/3989
Moreover, the market in the Europe region is estimated to hold a notable market share over the forecast period owing to the higher adaption of cutting-edge medical technologies and the significant investment in research and development activities in the region. For instance, Europe’s research and development spending as a percentage of gross domestic product (GDP) increased to 2.32% in 2020 from 2.23% the year before. Additionally, the existence of significant clinical research organizations in the region is predicted to fuel the market growth over the forecast period.
The study further incorporates Y-O-Y growth, demand & supply and forecast future opportunity in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).
The global micro syringes market is segmented by type into auto samplers, manual, and others. Out of these, the auto samplers segment is expected to gain a maximum market share over the forecast period owing to several benefits of the auto sampler, including good repeatability, superior efficiency, and greater accuracy. As per the research report, it was found that more than 3 billion auto-sampler syringes are secured by UNICEF in 2022 for routine immunizations and COVID-19 needs. In addition to this, the auto sampler syringe is widely used for chromatography, given to its precision, time-saving, large sample storage, and accurate sample selection characteristics. It was observed that in the numbered places of the auto sampler tray, 100 samples or standards—or much more be loaded at once and selection is accurate without mistake which is more common with manual syringes.
Get a Sample PDF of Micro Syringes Market Report@ https://www.researchnester.com/sample-request-3989
Further, the global micro syringes market is segmented by needle type into fixed and removable. Out of these, the removable segment is estimated to hold the largest market share over the forecast period owing to its versatility as different needle sizes can be used on the same syringe barrel as the needles are replaceable in the event of bending. They come in a range of lengths and point configurations as well. In addition to this, the reusability of this syringe makes it the smart syringe and even WHO advocates the re-usage of the smart syringe, which in turn can contribute to limiting the waste generated by healthcare industries. As per the one of the environmental surveys, approximately 85% of the trash produced by health care activities is general, non-hazardous waste. The remaining 15% is classified as hazardous material, which may be radioactive, poisonous, or contagious. Moreover, the rising demand for removable needle-type smart syringes and the efforts of key market players to make them cost-competitive are expected to drive the segment growth over the forecast period. It is believed that syringes without safety measures cost USD 0.03 to 0.04. The price of the new "smart" syringes is at least double that. But, estimated to fall in price with rising demand.
For more insights on the market share of various regions: https://www.researchnester.com/sample-request-3989
The global micro syringes market is also segmented on the basis of end user.
Global Micro Syringes Market, Segmentation by End User
Some of the prominent key players and their company profiling mentioned in the global micro syringes market research report include Innovative Labor Systeme GmbH, GL Science, Inc., PerkinElmer, Inc., Trajan Scientific and Medical, Agilent Technologies, Inc., Shimadzu Corporation, Avantor, Inc., ITO Corporation, Merck KGaA, Thermo Fisher Scientific Inc., and other key market players. The profiling enfolds growth opportunities, challenges, and market trends prevalent for the growth of the market during the forecast period.
Do You Have Any Query Or Specific Requirement? Ask to Our Expert: https://www.researchnester.com/ask-the-analyst/rep-id-3989
Explore Our Recent Related Reports:
ASEAN Disposable Syringes Market Segmentation by Type (General/Conventional, Safety, and Pre-Filled Syringes); by Syringe Tip (Luer-Lock, Slip, Eccentric, and Catheter Syringe Tips); by Application (Immunization Injections, Therapeutic Injections, and Others); and by End-User (Hospitals, Diagnostic Laboratories, Blood Banks, Pharmaceutical Companies, Others) – Demand Analysis & Opportunity Outlook 2021-2031 Special Purpose Needle Market : Global Demand Analysis & Opportunity Outlook 2023 Huber Needles Market : Global Demand Analysis & Opportunity Outlook 2024
Needle Free Insulin Devices Market: Global Historical Growth (2012-2016) & Future Outlook (2017-2024) Demand Analysis & Opportunity Evaluation Cardiovascular Needle Market By Product (Round bodied needles, Cutting needles); By Usage (Single use needles, Multiple use needles); By End-User Industries (Hospitals, Clinics, Ambulatory surgical centers) - Global Demand Analysis & Opportunity Outlook 2027
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.
Contact for more Info: AJ Daniel Email: info@researchnester.com U.S. Phone: +1 646 586 9123 U.K. Phone: +44 203 608 5919
For More Update Follow: - LinkedIn | Twitter | Facebook | Xing
Investors are trying to make sense of the markets, in face of conflicting signals. Year-to-date, we’re facing deep losses – but more recently, a sharp rally despite this week’s confirmation that we’re in a recession. Government data released on Thursday showed a 0.9% GDP contraction in Q2, which came on the heels of a 1.6% contraction in Q1. That’s two quarters in a row, the definition of a recession. Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program, reminds us the ‘conventional wis
Looking to buy the dip? Start here.
How far off is The Boeing Company ( NYSE:BA ) from its intrinsic value? Using the most recent financial data, we'll...
Shares of the Illinois-based drugmaker AbbVie (NYSE: ABBV) were down by a hefty 5% as of 2:32 p.m. ET Friday afternoon. As a result, the Dividend Aristocrat's market capitalization has slipped by a staggering $13.2 billion today. Ahead of the opening bell, AbbVie announced its 2022 second-quarter earnings.
This has been a year to remember for investors in seemingly all the wrong ways. Since the major U.S. indexes hit their respective all-time closing highs between mid-November and the first week of January, the timeless Dow Jones Industrial Average, broad-based S&P 500, and growth-driven Nasdaq Composite (NASDAQINDEX: ^IXIC) have shed as much as 19%, 24%, and 34% of their value. You'll note by the drop in the S&P 500 and Nasdaq that both indexes have entered a bear market.
When Elon Musk decided to terminate his $44 billion deal to purchase Twitter the social-media company sued in the Delaware Court of Chancery. Twitter is suing for “specific performance,” a rare remedy that would require Musk to complete the merger. Unfortunately for Twitter, it isn’t Elon Musk Inc. but Elon Musk the individual who offered to buy the company.
Each of these five real estate investment trusts (REITs) currently pays a dividend of greater than 5%. For those willing to accept the risks, that’s a better yield than that of the U. S. Government 10-Year Treasury Note. Each REIT trades on the New York Stock Exchange, so plenty of information on these REITs is available from analysts at respected investment firms. Looking for ways to boost your returns? Check out Benzinga's coverage on Alternative Real Estate Investments: Exclusive Offering For
Apple delivered better-than-expected earnings and shares are now up 25% from the June low. Here's how to trade it from here.
A slowing economy is slowing ad spending. Long-term investors should use this weakness to pick up winners while they're on sale.
Alibaba Group Holding has been added to a growing list of Chinese companies that face potential delisting from US stock exchanges, days after the e-commerce giant announced plans to seek a primary listing on Hong Kong's bourse with the aim to diversify its investor base. The US Securities and Exchange Commission (SEC) on Friday included Alibaba, owner of the South China Morning Post, to its watch list of US-listed Chinese firms that face removal from American exchanges under a 2020 law, the Hold
Rio Tinto Group ( LON:RIO ) investors will be delighted, with the company turning in some strong numbers with its...
(Bloomberg) -- Investors should stay wary of US stocks and bonds as inflation remains a threat and recession looms, according to Rebecca Patterson, chief investment strategist at Bridgewater Associates.Most Read from BloombergThe Crypto Collapse Has Flooded the Market With Rolex and PatekShock July Stock Rally Was a Monster the Fed May Regret SeeingMeet the Russian Architect of Putin’s Economic CounterattackMonkeypox is Spreading Fast. Now Kids Are Getting It, TooThe stock market, which finished
We feel now is a pretty good time to analyse Tilray Brands, Inc.'s ( NASDAQ:TLRY ) business as it appears the company...
We don’t advocate for theft. But stealing these strategies is a victimless crime.
Shares of Roku (NASDAQ: ROKU) opened sharply lower on Friday after a blistering financial update. Roku's plummet to close out the trading week is fair. The ad market has softened swiftly, even for Roku's connected TV stronghold that should've held up better than other marketing markets.
After dropping for the first 5 ½ months of the year, the S&P 500 has rebounded 8.5% since June 15 and 4.7% since July 26, the day before the Federal Reserve raised interest rates. Investors have turned enthusiastic toward stocks partly because Fed Chairman Jerome Powell said after the rate hike that the central bank will eventually slow its rate hike campaign. Never mind that the Fed said in its statement announcing the rate increase that it "anticipates that ongoing increases in the target range [for the federal funds rate] will be appropriate."
British American Tobacco p.l.c.'s ( LON:BATS ) investors are due to receive a payment of £0.5445 per share on 10th of...
Ford Motor lifted its quarterly dividend to 15 cents a share, a 50% boost, while Hershey raised its payout by 15%.
If you still think you can't find winning stocks in the S&P 500, you're not looking hard enough.
In this article, we discuss the 7 stocks that Cathie Wood dumped in July. If you want to see more stocks that she disposed of during this month, click Cathie Wood Dumped These 3 Stocks in July. In June, Cathie Wood’s ARK Investment Management suffered a sharp decline in assets, which was decidedly higher than […]